Axcella Therapeutics to Participate in the H.C. Wainwright Global Investment Conference

Rhea-AI Summary

Axcella Therapeutics (Nasdaq: AXLA) announced participation in the H.C. Wainwright Global Investment Conference from September 12-14, 2022, in New York City. Management will engage in a fireside chat on September 13 at 10:30 AM ET, accessible via webcast. A replay will be available for 90 days on the company's website. Interested investors can request one-on-one meetings, either virtually or in-person. Axcella is focused on treating complex diseases with endogenous metabolic modulator compositions, having candidates in development for Long COVID and NASH.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Axcella Therapeutics (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions, today announced that management will participate in a fireside chat and one-on-one meetings at the H.C. Wainwright Global Investment Conference taking place September 12 – 14, 2022 both virtually and in-person in New York City.

Details for the fireside chat are as follows:

Date:		Tuesday, September 13, 2022
Time:		10:30 am Eastern Time
Webcast:		https://journey.ct.events/view/6604fa89-69be-476a-b518-b615e1ac7fb6

The conference call webcast will be accessible in the Investors & News section on the company’s website at www.axcellatx.com. An archive of the webcast replay will be available on the Company’s website for up to 90 days.

To request a one-on-one in-person or virtual meeting, please register here.

Internet Posting of Information

Axcella uses the “Investors and News” section of its website, www.axcellatx.com, as a means of disclosing material nonpublic information, to communicate with investors and the public, and for complying with its disclosure obligations under Regulation FD. Such disclosures include, but may not be limited to, investor presentations and FAQs, Securities and Exchange Commission filings, press releases, and public conference calls and webcasts. The information that we post on our website could be deemed to be material information. As a result, we encourage investors, the media and others interested to review the information that we post there on a regular basis. The contents of our website shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

About Axcella Therapeutics (Nasdaq: AXLA)

Axcella is a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using compositions of endogenous metabolic modulators (EMMs). The company’s product candidates are comprised of EMMs and derivatives that are engineered in distinct combinations and ratios to reset multiple biological pathways, improve cellular energetics, and restore homeostasis. Axcella’s pipeline includes lead therapeutic candidates in Phase 2 development for the treatment of Long COVID and NASH. The company’s unique model allows for the evaluation of its EMM compositions through non-IND clinical studies or IND clinical trials. For more information, please visit www.axcellatx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220912005400/en/

Ashley Robinson

arr@lifesciadvisors.com

(617) 430-7577

Source: Axcella Therapeutics

FAQ

When is Axcella participating in the H.C. Wainwright Global Investment Conference?

Axcella will participate in the H.C. Wainwright Global Investment Conference from September 12-14, 2022.

What time is Axcella's fireside chat at the conference?

The fireside chat is scheduled for September 13, 2022, at 10:30 AM Eastern Time.

How can I access Axcella's conference call webcast?

The conference call webcast can be accessed on Axcella's website under the Investors & News section.

What are the main focus areas for Axcella's product candidates?

Axcella is developing therapeutic candidates targeting Long COVID and NASH.

How long will the webcast replay of Axcella's fireside chat be available?

The webcast replay will be available for up to 90 days on Axcella's website.

How can investors request a meeting with Axcella during the conference?

Investors can request one-on-one in-person or virtual meetings by registering on the conference website.